A patient living with diabetes who is also trying to quit smoking might reasonably choose a GLP-1 drug over another glucose-lowering medication, not because it is approved for smoking cessation, but because it may help them quit, a benefit that other diabetes drugs do not offer
For injury healing (muscles, tendons, ligaments) Standard protocol: Dose: 250-500mcg twice daily (500mcg-1mg total daily) Method: Injectable SubQ near injury site Duration: 4-8 weeks minimum Timing: Morning and evening Severe injuries: Dose: 500mcg twice daily (1mg total daily) Method: Injectable SubQ Duration: 8-12 weeks Can extend if needed Mild injuries: Dose: 250mcg twice daily (500mcg total) Method: Injectable SubQ Duration: 4-6 weeks Use our BPC-157 dosage calculator and BPC-157 5mg dosing guide
Consult with your GP Before making any changes to your medication plan, you must consult with your GP
A hospital cohort (n=8,103) and a community MASLD cohort (n=120,166) validated the high SAFE score (100) for HCC risk prediction
doi: 10.1186/s12866-023-02925-7 53 ShkoporovANHillC
5c and Supplementary Fig
